Breast cancer
Results
Phase 2
This trial looked at pertuzumab with trastuzumab and a type of hormone therapy called an aromatase inhibitor.
It was for women whose breast cancer had and . And had spread to surrounding tissue or to another part of the body.
The trial was open for people to join between 2012 and 2014. The trial team published results in 2018.
Recruitment start: 1 May 2012
Recruitment end: 31 July 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Schmid
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 10 Oct 2022
CRUK internal database number: 9035
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
